ImmuneSpec BV

Startup

ImmuneSpec is a Belgian CRO bringing high-sensitivity immunopeptidomics to vaccine development. Our MAPPs platform identifies truly pathogen-derived, MHC-presented antigens to enable optimized antigen selection and refined epitope presentation for broad-spectrum immunity. We also validate construct design to ensure effective antigen presentation. Beyond vaccines, our platform supports immunogenicity risk assessment of biotherapeutics and neoantigen discovery in immuno-oncology.

Visit our booth at World Vaccine Congress Europe 2026 to learn more about our services and explore collaboration opportunities.

website